USPTO Deadlines
Application History
16 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 5, 2011 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Dec 5, 2011 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| May 6, 2011 | NAUD | R | REPORT UNRESPONSIVE AMENDMENT - COMPLETED |
| May 6, 2011 | GAUD | O | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| May 6, 2011 | GAUN | O | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Mar 17, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 17, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 10, 2011 | ALIE | A | ASSIGNED TO LIE |
| Feb 28, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 13, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 13, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 13, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 27, 2010 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 28, 2010 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED |
| Jul 27, 2010 | NWAP | I | NEW APPLICATION ENTERED |
| Jul 27, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 005
Homeopathic pharmaceuticals for use in the treatment of sexual dysfunction; We will limited the use of the product as Homeopathic pharmaceutical. Due to FDA label guidelines, it is mandatory to indicate on the front label of the package that it is an Homeopathic medicine so there is no risk of confusion with any other medicine either allopathic or alternative
First Use Anywhere:
May 15, 2010
First Use in Commerce:
Jul 15, 2010
Additional Information
Design Mark
The mark consists of the words "GUNA-VENUS" divided by an hyphen and the symbol of femininity.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005